Allarity Therapeutics, Inc. (ALLR) Financial Statements (2024 and earlier)

Company Profile

Business Address 24 SCHOOL ST., 2ND FLOOR
BOSTON, MA 02108
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,029,00019,555,000
Cash and cash equivalents2,029,00019,555,000
Receivables  
Prepaid expense591,00036,000
Other current assets1,559,000625,000
Other undisclosed current assets 789,000838,000
Total current assets:4,968,00021,054,000
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization 6,00086,000
Property, plant and equipment21,0008,000
Long-term investments and receivables  350,000
Long-term investments  350,000
Intangible assets, net (including goodwill)9,549,00028,135,000
Intangible assets, net (excluding goodwill)9,549,00028,135,000
Total noncurrent assets:9,576,00028,579,000
TOTAL ASSETS:14,544,00049,633,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,155,00010,489,000
Taxes payable113,000
Employee-related liabilities1,088,000
Accounts payable6,251,000698,000
Accrued liabilities1,904,0008,590,000
Debt2,644,0001,000,000
Derivative instruments and hedges, liabilities374,00074,000
Other undisclosed current liabilities49,0009,156,000
Total current liabilities:11,222,00020,719,000
Noncurrent Liabilities
Long-term debt and lease obligation 9,000
Long-term debt, excluding current maturities  
Liabilities, other than long-term debt1,432,00010,121,000
Accumulated deferred investment tax credit 1,083,000979,000
Deferred income tax liabilities349,0001,961,000
Operating lease, liability  9,000
Derivative instruments and hedges, liabilities  7,181,000
Total noncurrent liabilities:1,432,00010,130,000
Total liabilities:12,654,00030,849,000
Temporary equity, carrying amount 2,003,000 
Equity
Equity, attributable to parent(113,000)18,152,000
Preferred stock  
Common stock 2,000810,000
Additional paid in capital83,156,00084,434,000
Accumulated other comprehensive loss(721,000)(600,000)
Accumulated deficit(82,550,000)(66,492,000)
Other undisclosed equity  632,000
Total equity:(113,000)18,784,000
TOTAL LIABILITIES AND EQUITY:14,544,00049,633,000

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
Gross profit:(51,000)(51,000)
Operating expenses(34,463,000)(26,556,000)
Other undisclosed operating income51,00051,000
Operating loss:(34,463,000)(26,556,000)
Nonoperating income (expense)16,884,000(549,000)
Investment income, nonoperating (85,000)(495,000)
Loss, foreign currency transaction, before tax (913,000)(95,000)
Other nonoperating income 41,000
Interest and debt expense(12,000)(99,000)
Loss from continuing operations before income taxes:(17,591,000)(27,204,000)
Income tax expense (benefit)1,521,000(133,000)
Loss from continuing operations:(16,070,000)(27,337,000)
Loss before gain (loss) on sale of properties:(27,337,000)
Other undisclosed net income12,000689,000
Net loss:(16,058,000)(26,648,000)
Other undisclosed net income attributable to parent  
Net loss attributable to parent:(16,058,000)(26,648,000)
Preferred stock dividends and other adjustments(5,947,000) 
Other undisclosed net income available to common stockholders, basic5,947,000 
Net loss available to common stockholders, diluted:(16,058,000)(26,648,000)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
Net loss:(16,058,000)(26,648,000)
Other comprehensive income (loss)121,0001,966,000
Other undisclosed comprehensive income  
Comprehensive loss:(15,937,000)(24,682,000)
Comprehensive loss, net of tax, attributable to noncontrolling interest  
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(242,000)(3,941,000)
Comprehensive loss, net of tax, attributable to parent:(16,179,000)(28,623,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: